Biomarkers of high-grade serous ovarian carcinomas
Abstract
The present disclosure provides biomarkers useful for determining the prognosis of conditions such as ovarian cancer. The presently disclosed subject matter provides angiogenic biomarkers and methods and compositions for predicting overall survival (OS) in women with high-grade serous carcinomas (HGSCs). The presently disclosed subject matter provides compositions and methods that enable rationally directed therapies to improve outcome in women with HGSC.
- Inventors:
- Issue Date:
- Research Org.:
- Duke Univ., Durham, NC (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1532021
- Patent Number(s):
- 9771620
- Application Number:
- 14/282,603
- Assignee:
- Duke University (Durham, NC)
- Patent Classifications (CPCs):
-
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2014-05-20
- Country of Publication:
- United States
- Language:
- English
Citation Formats
Reihani, Sharareh, Secord, Angeles Alvarez, Dewhirst, Mark W., Jiang, Chen, and Owzar, Kouros. Biomarkers of high-grade serous ovarian carcinomas. United States: N. p., 2017.
Web.
Reihani, Sharareh, Secord, Angeles Alvarez, Dewhirst, Mark W., Jiang, Chen, & Owzar, Kouros. Biomarkers of high-grade serous ovarian carcinomas. United States.
Reihani, Sharareh, Secord, Angeles Alvarez, Dewhirst, Mark W., Jiang, Chen, and Owzar, Kouros. Tue .
"Biomarkers of high-grade serous ovarian carcinomas". United States. https://www.osti.gov/servlets/purl/1532021.
@article{osti_1532021,
title = {Biomarkers of high-grade serous ovarian carcinomas},
author = {Reihani, Sharareh and Secord, Angeles Alvarez and Dewhirst, Mark W. and Jiang, Chen and Owzar, Kouros},
abstractNote = {The present disclosure provides biomarkers useful for determining the prognosis of conditions such as ovarian cancer. The presently disclosed subject matter provides angiogenic biomarkers and methods and compositions for predicting overall survival (OS) in women with high-grade serous carcinomas (HGSCs). The presently disclosed subject matter provides compositions and methods that enable rationally directed therapies to improve outcome in women with HGSC.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2017},
month = {9}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.